Certara & Dizal Partner to Fast-Track FDA Approval of Sunvozertinib for Lung Cancer Case Study Certara 与迪哲强强联手助力舒沃替尼斩获FDA肺癌适应症加速批准 Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…Certara2025 年 10 月 2 日
37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) Conference 37th Annual Meeting of the Southern California Chapter Society of Toxicology (SCCSOT) Certara2025 年 9 月 22 日
Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool Announcement Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool RADNOR, Pa. – 2025 年 9 月 17 日 – Certara, Inc. (纳斯达克股票代码:CERT), a global leader in…Certara2025 年 9 月 17 日
Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Guide Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…Certara2025 年 9 月 11 日
Redefining Every Stage of Investment (RESI) Seed to Exit Conference Redefining Every Stage of Investment (RESI) Seed to Exit –Certara2025 年 9 月 5 日
The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Conference The Pharmacometrics Africa Conference 2025 (PMXAC-2025) Certara2025 年 9 月 4 日
Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies Live Events Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies – London, UKCertara2025 年 9 月 4 日
The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape On-Demand Webinar The Pursuit of Certainty: Integrated Evidence and the evolving drug development and reimbursement landscape Watch leading experts from Pfizer, Merck, Amicus, and Certara discuss how Integrated Evidence can bridge…Certara2025 年 9 月 3 日
Designing a High-Value Drug Development Program: From Concept to First-in-Human (FIH) On-Demand Webinar 设计高价值药物研发计划:From Concept to First-in-Human (FIH) Learn to design drug development programs for First-in-Human (FIH) success with biomarkers, PK/PD modeling, and…Certara2025 年 8 月 29 日
Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value On-Demand Webinar Blueprint for Biotech Success: De-risking Early Development to Secure Long-Term Value Discover strategies to cut risk, speed timelines, and boost investor confidence in early biotech development.Certara2025 年 8 月 21 日